空气过敏原敏感化对成年人的支气管过敏反应的影响
Onur Telli1, Kurtulus Aksu1, Ozgur Akkale1
1From the Department of Immunology and Allergy, Ankara Ataturk Sanatorium Training and Research Hospital, University of Health Sciences, Ankara, Turkey and.
Allergy and asthma proceedings
|September 17, 2025
概括
季节性和多年性过敏原都会增加喘患者支气管过敏反应 (BHR) 的风险. 对过敏原的敏感性,特别是长年过敏原的敏感性,显著提高了BHR的风险,突出了避免过敏原的重要性.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 肺部病理学 肺部病理学
- 临床医学 临床医学
背景情况:
- 季节性过敏原和过敏性鼻炎之间的联系已经确立,但其与喘严重程度的关联仍在争论中.
- 关于季节性过敏原敏感化对喘的影响存在相互矛盾的研究.
- 这项研究探讨了过敏原敏感化在患有喘症状的个体中支气管过敏反应 (BHR) 的作用.
研究的目的:
- 为了确定季节性过敏原敏感化对支气管过敏反应 (BHR) 严重性的影响.
- 在患有喘症状的患者中确定影响BHR的因素.
- 在没有先前存在慢性呼吸道疾病的成年人中调查过敏原敏感性.
主要方法:
- 成年患有喘症状 (呼吸不全,喘息,咳) 的患者从过敏门诊处招募 (2016-2023年).
- 患者接受了支气管诱导测试 (BPT) 进行喘诊断;那些患有COPD或支气管切除症的人被排除在外.
- 收集的数据包括人口统计,临床特征,BPT结果,皮肤刺伤测试,IgE水平和过敏史.
主要成果:
- 在325名参与者中,有40.3%的参与者表现出对空气过敏原的敏感性 (单一或多重).
- 32.3%的患者患有支气管过敏反应 (BHR);其中69.5%的患者有过敏原敏感性.
- 过敏原敏感性显著增加了BHR风险:多年性 (7.13x),季节性 (4.14x) 和两者 (8.67x).
结论:
- 季节性和多年性过敏原敏感性都与支气管过敏反应 (BHR) 的风险增加有关.
- 这些发现强调了过敏原暴露对喘相关的呼吸道过敏反应的重大影响.
- 识别和管理过敏原敏感性对于控制喘患者的BHR至关重要.
相关概念视频
Allergic Reactions
32.1K
Overview
32.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K


